AUTM on the Air

Federal funding shakeups and new cost caps are hitting Tech Transfer offices from multiple angles. Jodie Richardson, Director of Customer Success at TechPipeline and Chair of AUTM’s Annual Meeting Planning Committee, has been right in the middle of these conversations. With a background in strategic planning, cross-functional leadership, and compliance, she’s been gathering insights from leaders across the country on how they’re coping along with what might come next.Her recent article, Weathering the Storm: How TTOs are Navigating Overhead Rate Caps and Federal Funding Challenges, dives into the real-world effects of these changes. In this conversation, Jodie talks about the hiring freezes and budget cuts many offices are facing, the drop in invention disclosures, and why those shifts could have lasting consequences for commercialization pipelines, startups, and research infrastructure. She also shares how teams are rethinking patent strategies, keeping industry relationships steady in a volatile climate, and preparing for an unprecedented level of federal compliance scrutiny.The discussion reaches into other stress points too including uncertainty around SBIR/STTR funding, the added hurdles in international collaborations, and the scramble to find alternative funding through alumni networks, foundations, and state programs. Jodie offers ideas for retaining talent, boosting staff morale, and making sure the public understands just how much academic research shapes everyday life. Even with all the challenges, she sees reason for optimism, pointing to the adaptability and problem-solving spirit that has always defined the tech transfer community.In This Episode:[01:12] Jodie explains what prompted her to write the article and how she brought together senior Tech Transfer leaders to talk through the fast-moving changes, challenges, and strategies.[03:22] She describes the anxiety and uncertainty created by daily breaking news affecting research and the innovation ecosystem.[05:19] The new 15% indirect cost cap from NIH, DOE, NSF, and now DOD is creating immediate concern, leading to hiring freezes, budget freezes, and reduced invention disclosures.[06:48] Staffing shortages are adding pressure to existing Tech Transfer staff who are trying to maintain operations and support faculty.[08:21] Researchers are spending more time securing alternative funding, adding to the workload for TTO staff who were already under stress.[09:40] Jodie outlines the potential long-term risks to commercialization pipelines, startup formation, and the wider innovation ecosystem if disclosure declines continue.[10:53] Patent strategies are shifting, with offices becoming more selective about filings, especially international patents, and focusing resources on cases with strong commercialization prospects.[12:17] Green energy, climate tech, biotech, and vaccine technologies are among the areas seeing greater selectivity.[13:04] Industry hesitation is impacting both sponsorships and licensing deals, with some master research agreements put on hold indefinitely.[14:57] Communication is key. Offices are proactively engaging with industry sponsors and licensees to understand concerns and salvage opportunities.[15:45] On August 8, the Trump administration announced a federal review of Harvard’s patents, threatening to exercise Bayh-Dole march-in rights.[17:35] Jodie talks about the unprecedented scale of this review and the short 30-day timeline to respond for thousands of inventions.[19:22] She stresses the importance of thorough documentation, compliance audits, and internal collaboration within the TTO.[22:41] The future of SBIR/STTR programs is uncertain, and startups are concerned about potential changes to qualification requirements and funding levels.[24:33] TTOs are partnering with venture support programs, industry engagement, and sponsored programs offices to help startups navigate possible funding gaps.[25:47] International collaborations face more red tape, with abrupt halts to some projects and tighter screening for partners in countries like China and Russia.[28:34] Ensuring licensees meet U.S. manufacturing requirements is becoming a greater priority in international deals.[29:21] Alumni foundations and state economic development programs are emerging as important sources of alternative funding.[31:28] Some states have increased funding to offset reductions in federal research dollars, though most cannot fully close the gap.[33:05] Jodie warns of the potential erosion of research infrastructure and loss of innovation leaders if talent leaves the U.S.[35:42] Institutions can help retain faculty and researchers by stepping in to support projects when funding is lost and easing the commercialization burden.[37:52] Shifts in research focus toward “safer” areas could reduce groundbreaking, high-risk innovations such as climate tech, vaccine development, and women’s health research.[39:35] Staff morale is being tested by uncertainty; transparent communication and safe spaces for discussion are critical.[42:21] National meetings like AUTM’s annual gathering provide opportunities for shared support, optimism, and advocacy.[43:40] Jodie sees a need for greater public education about how federally funded research works and the technologies it produces.[46:01] Even with the challenges, Jodie remains optimistic about the adaptability and resilience of the tech transfer community.Resources: Jodie Richardson - Tech PipelineJodie Richardson - LinkedInWeathering the Storm: How TTOs are Navigating Overhead Rate Caps and Federal Funding ChallengesSBIR/STTR Programs

America's leadership in global innovation depends on the critical link between federal policy and scientific funding. Cuts to research budgets, restrictions on international visas, and the rollback of diversity programs are converging to create uncertainty that threaten labs, universities, and communities that depend on them. What happens in the next budget cycle will determine whether the U.S. continues to set the pace for global discovery or risks ceding that ground to competitors eager to recruit American-trained talent.I’m thrilled to welcome back Kate Zernike, Pulitzer Prize–winning national correspondent for The New York Times. Kate brings both personal understanding and journalistic rigor to covering science policy. Her grandfather was Nobel Prize–winning physicist Frits Zernike, and she has spent decades reporting on the politics of research and innovation. She is perhaps best known for breaking the 1999 story of MIT’s admission that it had discriminated against women on its faculty. This reporting laid the foundation for her acclaimed 2023 book The Exceptions: Nancy Hopkins, MIT, and the Fight for Women in Science. Her distinguished career also includes a Pulitzer for explanatory reporting on Al Qaeda in 2002, underscoring her ability to connect complex issues to the human stories behind them. In this episode, we discuss her recent reporting on two pivotal articles: U.S. Scientists Warn That Trump’s Cuts Will Set Off a Brain Drain and The Surprising Scientists Hit by Trump’s DEI Cuts. She explains how uncertainty is pushing young researchers to reconsider careers in science, forcing labs to halt promising projects such as mRNA cancer research, and eroding public trust in the scientific enterprise after COVID. She also reveals a surprising twist where many of the scientists most affected by DEI rollbacks are rural, first-generation, and conservative-leaning students who depended on those programs to access research careers. We also take on the breaking news of the federal government’s unprecedented investigation into Harvard’s patents under the Bayh-Dole Act, a move that raises profound questions about intellectual property, peer review, and the future of university–industry partnerships.In This Episode:[02:10] We’ll discuss Kate’s June 3rd article on Trump’s proposed funding cuts and the potential “brain drain” in U.S. science.[04:45] The American Dream story of Nobel laureate Ardem Patapoutian and concerns from scientists at Harvard and Johns Hopkins.[06:00] Why U.S. science relies heavily on international talent and the risks of disrupting this pipeline.[07:23] Cultural differences and how countries like India prioritize science as a top career path compared to the U.S.[08:23] Evidence of China, France, Germany, and others actively recruiting American-trained scientists.[10:03] Historical perspective and the migration of rocket scientists after WWII and how talent shaped U.S. supremacy in science.[12:22] NIH and NSF budget cuts, with biotechnology and computer science research seen as most vulnerable.[15:30] How federal research funding connects to U.S. competitiveness and public misconceptions of science.[18:45] Making the case for better science communication and opening up opportunities in science. [20:35] We talk about DEI grant cuts and the impact on rural and socioeconomically diverse scientists.[21:35] Stories of researchers like Lucas Dillard, Gabrielle Merchant, Ashley Albright, and Nicole Gross losing critical grants.[23:50] The lingering resentment toward science post-COVID and challenges in rebuilding public trust.[24:48] Simultaneous threats including funding cuts, talent loss, DEI program eliminations, and IP risks are compounding uncertainty.[27:00] The taxpayer debate and making the case for return on investment from university research.[29:20] Key message to policymakers is that sustained funding is essential to avoid halting critical discoveries.[30:01] Cancer research and mRNA projects at risk, including prostate cancer studies being shut down.[31:30] What gives Kate hope includes pushback from within the government, and scientists’ enduring joy, and commitment to discovery.[32:54] Where to find Kate’s articles and book, and a call to policymakers ahead of the 2026 budget cycle!Resources: Kate ZernikeKate Zernike - New York TimesKate Zernike - LinkedInExposing Discrimination in Science: The Story of Nancy Hopkins and MIT with Kate ZernikeU.S. Scientists Warn That Trump’s Cuts Will Set Off a Brain DrainThe Surprising Scientists Hit by Trump’s DEI CutsThe Exceptions: Nancy Hopkins, MIT, and the Fight for Women in ScienceFrits Zernike

The McGill Innovation Fund was created to fill a big gap in early-stage research funding and help promising ideas make the leap from the lab into the real world. In this episode, Senior Communications Advisor Junji Nishihata shares the story of how the fund came about in 2021, just as McGill University was marking its 200th anniversary, and why it’s different from other campus competitions. Instead of focusing on general entrepreneurship, the MIF is tied directly to research through a formal report of invention. With three funding tiers ranging from $25,000 to $100,000 and a yearly budget of up to $350,000, it offers serious support to faculty, startups, and researchers looking to license their work.But money is only part of the equation. Junji talks about the year-long support program that comes with every award bringing together alumni advisors, targeted mentorship, and practical workshops on everything from market strategy to regulatory pathways. The alumni network plays a huge role here, offering time, connections, and hard-won experience to help teams move forward.We also get an inside look at success stories like cleantech startup Altiro Energy and biotech company DendroTEK, plus a peek at what’s ahead for the fund. From themed competitions in AI and clean tech to a possible high-profile pitch day, the MIF is working to break down the “ivory tower” perception of academic research and show its real-world value.In This Episode:[01:15] The McGill Innovation Fund started when McGill University was looking forward to its 200th anniversary in 2021. They were looking for big moonshot ideas that they could use to excite alumni around the world.[02:05] At first they thought about making an investment fund, then they decided to focus on funding for early stage ideas.[02:50] Eligibility criteria include a report of invention because it's based on research. They declare what the concept is and then the technology transfer team examines it in detail. Is it novel? Is it patentable?[04:06] The objective of the innovation fund is to get stuff out of the lab and into the real world where it can make a difference.[06:07] The MIF is divided into three different prize tiers: the Discover at $25,000, the Develop at $50,000, and the Deploy at $100,000.[06:53] The yearly funding of a significant sum of money shows the university's commitment to innovation.[07:27] The initial funding came from royalties collected from past Innovation successes.[08:21] This shows that the university is serious about inventors and technology.[09:02] They are moving towards donor and corporate support.[10:16] The McGill Alumni Network is tremendous and has a lot of successful people who are willing to give back.[11:11] Junji shares more about the award tiers. [12:28] The McGill AMR Center or Antimicrobial Resistance Center offers a $75,000 top off in addition to the original award.[14:05] How the fund has created transformations. Altiro energy came to them in the development stage and became successful and moved on.[15:29] We learn about the support that is offered as well as funding. The big value comes in the support that follows the award. They develop a road map in conjunction with their alumni experts. They also have a series of Advisory board meetings every two months.[17:45] They also have the McGillConnect platform.[18:22] Tony Falco is a mentor that has started three companies. He's been in the trenches and knows how to help the teams.[19:34] They have about 75 alumni that they reach out to.[20:11] We learn about the success of DendroTEK.[21:26] We talk about what is next for the fund and future ideas. He would like to grow it into something similar to Shark Tank and raise the profile of the alumni.[22:36] He wants to show people the value that is created for society.Resources: Junji Nishihata - McGill UniversityJunji Nishihata - LinkedInJunji Nishihata - InstagramMcGill Innovation FundMcGillConnect Platform

The Wisconsin Alumni Research Foundation, or WARF, was created 100 years ago. It was a daring idea to turn scientific discoveries into real-world applications. Today marks the 100th anniversary. Since 1925, WARF has played a pioneering role in encouraging innovation, supporting scientific discovery, and ensuring that research at the University of Wisconsin-Madison benefits society.To commemorate a century of influence, we're joined by four members of the WARF team, each with their own take on the past and future. Holly Adams, Contract Manager; Lesli Mark, Accelerator Manager; Michael Falk, Chief Intellectual Property and Licensing Officer; and Maureen Miner, Director of Human Resources and Cultural Advancement.In this episode, we reflect on WARF's impact over the last century, from shaping national policy through the Bayh-Dole Act to commercializing breakthrough technologies in stem cell research, agriculture, and medical imaging.You'll learn how the team is evolving WARF's purpose through new programs like Startup Advantage, deeper industry involvement, and the intentional incorporation of AI into IP strategy. We also look at how WARF maintains its collaborative, mission-driven culture, and what this means for the next generation of researchers and innovators. It's a discussion about legacy, leadership, and what it takes to keep innovation going today and into the next century.In This Episode:[02:41] We learn what celebrating 100 years of WARF means to our guests personally and professionally. [03:37] WARF is an institution with stability even during ups and downs. It's a pleasure to serve a public research university.[04:07] Invest in research and make a difference. Turning university ideas into real world impact.[05:32] The Bayh-Dole Act was modeled on what WARF instituted and became a model for tech transfer around the country. [06:24] Technological contributions include work with stem cells.[07:51] How stem cell research helped a paralyzed man regain control of his extremities.[09:52] Holly talks about how the needs and complexities of licensing agreements have evolved over the years. They need to streamline the formation of startups coming out of Wisconsin-Madison.[10:29] The Startup Advantage Program is to help offset some of the costs that startups face.[11:16] Communication and a proactive approach is needed to create licensing agreements and needed changes.[12:06] How agreements and compliance have evolved overtime. They have a customized version of Salesforce and an online reporting tool.[13:39] The vital role of contract management with agreement obligations and compliance. Visiting local startups is also a great method.[14:43] Lesli is the Accelerator Manager for WARF.  A lot of their work is in licensing. There needs to be more advancement in these technologies coming off of campus. Methods of selecting technology and moving forward have changed.[16:22] Having subject matter experts helps accelerate the technology.[18:32] Identifying and supporting some of the most promising projects. They look at 400 disclosures a year and flag ones that they think will have market impact and need their help.[21:31] Opportunities and challenges of the next century of WARF include engaging with industry.[22:41] Michael talks about IP and licensing. They have always been inventor focused. Each disclosure is a product of an inventor's life's work.[24:26] Licensing success stories include advancements in medical imaging and radiopharmaceuticals and advances in agriculture.[27:22] AI challenges and opportunities and preparing for the future.[29:54] They are technology and inventor focused. Will a patent help a technology get out into the world?[32:09] Maureen talks about the people and the mission driven culture. A lot of people are engaged and excited about working at WARF. [33:35] They've focused on reaching everyone. All people can be inventors and they want to make sure that they can promote them and reach out.[34:13] They've been strategic about celebrating innovations.[35:02] They have a hybrid structure where they support and meet employees where they are. Along with a robust health and wellness program and benefits. They also encourage paid community involvement.[36:49] Taking the vision of WARF and turning it over to employees.[37:35] Michael is most proud of how researchers appreciate and respect WARF.[38:43] WARF offers employees the opportunity to learn and grow. [39:39] They are also very proud of the startups that they've been able to help.[40:07] Being a valued partner and being a helpful resource supports the culture. Along with connections with colleagues.[41:02] Carrying the WARF legacy forward. Resources: Wisconsin Alumni Research Foundation: WARFHolly Adams - WARFHolly Adams - LinkedInLesli Mark - WARFMichael Falk - WARFMaureen Miner - WARFMaureen Miner - LinkedIn

The blue economy is rapidly evolving. There’s a growing demand for innovation that’s both sustainable and scalable. Leading this work is Millicent Pitts, CEO and Executive Director of Ocean Exchange. Over the last ten years, she has helped the organization identify and support cutting-edge solutions that protect ocean health and strengthen coastal systems.Millicent spent three decades in the chemical and materials industry, holding senior roles at BASF, Engelhard, Arco Chemical, and more. She also earned her MBA from the Wharton School at the University of Pennsylvania. This background gives her a practical, business-minded approach to sustainability. She also serves as a mentor and judge for cleantech and ocean innovation competitions, including Creative Destruction Lab and NOAA’s Blue Economy Subcommittee.Ocean Exchange is a catalyst for turning research into real-world impact. Through its $100,000 Neptune Awards and collegiate grants, the organization has supported over 170 finalists who have collectively raised more than $3.2 billion in funding. Millicent discusses how these non-dilutive awards and mentorship programs help innovators move from idea to execution. We also discuss why Tech Transfer professionals play an important role in identifying talent and technologies that are suited for the blue economy.As one of just four national partners in NOAA’s Ocean Enterprise Accelerator, Ocean Exchange is expanding its reach through a well-funded initiative focused on ocean data, environmental resilience, and commercialization support. Today, we’ll highlight practical ways TTOs can engage, from encouraging student and faculty applications to joining review teams or helping innovators explore ocean use cases.In This Episode:[02:15] Millicent spent three decades in the chemical and materials industry. She benefited from working for companies that took environmental responsibility seriously.[03:22] Ocean Exchange has been around for 14 years and has a global reach. Their mission has always been to help advance the adoption of innovative solutions for healthy oceans and resilient coastal systems.[04:17] They moved from Savannah, Georgia to South Florida. South Florida is ground zero for many of these ocean and coastal system topics.[05:32] One of the things when she joined the organization was to make it more marketing and business friendly. [06:34] The more modern way of thinking of the blue economy embodies the idea that humans can use and interact with the ocean and not harm it.[07:22] In their 13 years of granting, they've had about 170 finalists who have raised 3.2 billion dollars. Most of it was in seed rounds and venture capital.[10:00] Ocean Exchange had a vision to find innovators and help their work have investment and societal impact.[13:17] Lives will be uplifted wherever these innovations are implemented.[14:04] How the ecosystem supports award applicants and winners beyond funding. A wide array of industry experts review the applications on impact, level of innovation, and ability to execute. This is part of their best network.[21:18] The $100,000 Neptune Awards. They take in philanthropy from families and corporations. After the selection process, they end up with 15 finalists. The award goes to any innovation about oceans and coastal systems.[22:55] Non-diluted funds are distributed meaning they don't take equity.[28:35] How tech transfer offices can leverage the collegiate awards which helps them reach undergraduates. Tech Transfer offices help connect the students.[33:13] We discuss applying to one or more of the NOAA accelerators. The National Oceanographic and Atmospheric Association, a part of the Department of Commerce, announced an accelerator program.[35:21] There are seven groups in the continuum that put forth a national model.[36:41] They want to reach more at the university and faculty level that have ocean use case innovations.[40:40] Each group gets a grant of 14 million dollars over 4 years. 40% of that will go through TDC Awards, Technology Development and Commercialization Awards.[41:13] Millicent manages these awards. The Great Lakes are also considered part of the ocean system. Most of the awards are between the range of 10,000 to 200,000 dollars.[42:30] You have to complete one of the accelerator programs also. You need to separately apply for the TDC award and say how you're going to use the money.[43:27] Goals include having at least $400,000 worth of non-dilutive grants.[45:18] She really wants Tech Transfer managers and executives to engage and maybe even be an expert on their review team. [46:14] There are great opportunities in the blue tech space, and they will help you through it.[46:40] Key deadlines: The collegiate grants have a deadline of September. There is still time if you're in the Americas to apply for the $100,000 award. Apply at Oceanexchange.org.Resources: Ocean ExchangeMillicent Pitts - LinkedInCreative Destruction LabNOAA Blue Economy SubcommitteeF6S PlatformMillicent.Pitts@OceanExchange.org(912) 257-0209

Clarity can come from lived experience, and Dr. Kirk Adams brings that clarity into every conversation about inclusion. After losing his vision at age five, he began a journey that would shape his life, and the lives of countless others. What started as a personal challenge became a lifelong mission to him. He wanted to create a world where people with disabilities are seen, valued, and included. This is a wonderful story of persistence, purpose, and real leadership.Dr. Adams has led some of the most influential organizations in the blindness and disability inclusion space. As the prior President and CEO of The Lighthouse for the Blind, Inc., and the American Foundation for the Blind, he focused on employment equity, community integration, and systemic change. He’s worked with tech giants like Google, Facebook, and Microsoft to make sure accessibility is part of the design. He’s also contributed to boards and task forces across sectors.Now as Managing Director of Innovative Impact, LLC, Dr. Adams partners with organizations to build cultures of inclusion from the inside out. He believes that accessibility is about connection, opportunity, and the kind of leadership that invites people to bring their full selves to work. His academic background, including a Ph.D. on the employment of blind adults in corporate America, only deepens his understanding of the structural barriers so many still face and what it takes to overcome them.In this episode, Dr. Adams shares lessons from his own journey, insights into the role of accessible innovation, and why hiring people with disabilities is smart business. Whether he’s talking about universal design or how to build trust through self-disclosure, he has a consistent message that inclusion benefits everyone. In This Episode:[04:44] We learn about Dr. Adams' personal journey of having detached retinas as a child and losing his vision.[05:29] His parents actually moved to Oregon, so he could go to the Oregon School for the Blind.[06:02] He was given three things at the school including skills needed for blind people such as traveling while blind and learning Braille. He was also given the gift of high expectations and the strong belief that he could overcome obstacles and solve problems.[07:53] He had strong internal locus control meaning he was able to do things.[08:26] After graduating from college, he had to go through the super arduous task of trying to find a job.[09:52] After working in finance, he pivoted into the nonprofit sector, so he could create environments and opportunities for other people with disabilities.[10:28] Leadership was the best lever he could use to create change. He got a masters and PhD in leadership because he felt this was the way to really implement change.[14:52] Common barriers to workforce inclusion for people with disabilities include transportation and employer attitudes. Many don't understand that the lived experience of disability gives people unique opportunities to develop strengths that are really important in the workplace.[17:13] The role of accessible innovation in creating a more inclusive workplace. We discuss the difference between an impairment and a disability.[19:05] We want to reduce disabling situations as much as we can.[20:37] Many people do not want to disclose their mental health issues. One of the best ways to help accommodate people with disabilities is to provide needed accommodations.[22:47] Measuring disability inclusion in the workplace.[24:34] Studies have shown that if 20% of the workforce has a disability, it becomes a better and more inclusive environment.[25:28] Having inclusion for people with disabilities through all the processes of tech transfer.[28:17] The importance of collecting demographic data for inclusion purposes.[31:10] How things have changed and inclusivity is now a matter of discussion. [32:02] Accelerating inclusion and encouraging the adoption of accessible technologies.[34:35] It's important to preserve implementation and enforcement of things like the American Disabilities Act. [35:31] How data for people with disabilities are underrepresented in large language models. Bias can be built into these models.[37:46] Projects and initiatives that Dr. Adams is currently working on include The Apex Program that helps launch blind people into cyber security careers.[39:50] The ultimate goal is to have the same outcomes for people with disabilities as the general population has.Resources: Dr. Kirk AdamsDr. Kirk Adams - LinkedInDr. Kirk Adams - YouTubeThe APEX Program

This month we are honoring the history, achievements, culture, and ongoing advocacy of people with disabilities. This is our third episode celebrating Disability Pride Month. Today, we're privileged to speak with Dr. Jutta Treviranus, a true pioneer in inclusive design. As the director of the Inclusive Design Research Centre (IDRC) at OCAD University in Toronto, Dr. Treviranus has been instrumental in shaping global accessibility laws and influencing the tech standards that major companies use. She has been constantly pushing the limits of what genuinely inclusive digital environments can be. Among her many achievements, she's been honored with the prestigious AI for Good - DEI AI Leader of the Year Award from Women in AI. Her entire approach is built on advocating for those whose experiences don't fit the "average" mold.In this episode, you'll learn about her "human starburst" metaphor and how it's changing design philosophy, why focusing on diversity at the edges of a system actually makes those systems more resilient and adaptable and what it really takes to confront bias in the age of AI. Dr. Treviranus shares powerful stories from the trenches, showing how inclusive design is a powerful driver for innovation that ultimately benefits us all.In This Episode:[02:22] Inclusive Design or the Canadian School of Inclusive Design is focused on an understanding that diversity is our greatest asset and inclusion is our greatest challenge.[03:28] The "human starburst" is a growing data set of what people need to thrive.[04:52] In the middle there's a cluster of 80% of the needs of all the population, the remaining 20% of the needs are distributed from that. The needs in the middle are more similar the further apart ones are different.[06:08] Most products designed are for the 80%.[07:22] The unexplored terrain leaves room for innovation.[08:01] The Canadian school starts at the edge and designs for those where things aren't working. It creates an adaptive environment.[09:17] Why inclusive design is critical in our digital age. We are replicating the same pattern instead of transforming. If we design our systems for people that are struggling, we will create things that work for us.[10:52] The inclusive masters program launched at OCAD University back in 2010. They wanted to ensure it meant the largest range of needs.[13:08] What Jutta feels are her significant contributions to inclusive design.[13:30] She's proud of the students who take this mindset and expand it and the organic growth of a new way of looking at things.[16:17] We learn about IDRC's We Count project. By the time chat GPT came out AI was already affecting major critical decisions in everyone's life.[17:27] If we continue this pattern we'll do quite a bit of harm to ourselves and outliers. Such as AI hiring where there's a pattern for the optimal employee. This can amplify discrimination already present and lead to monocultures.[19:29] It's a statistical reasoning machine with no guidance and nothing filtered out. Jutta is trying to address the needs of people who are vulnerable and most harmed by these systems.[21:31] There's an uptick in collateral damage to people who aren't like the average, including iatrogenic death and illness.[23:01] We Count is trying to invert the algorithm and look for different perspectives.[25:48] We Count has been in existence since 2016.[28:07] The importance of engaging the intended beneficiaries and the people who have the most difficulty with whatever you're designing.[29:40] What tech transfer students should know about innovation and inclusion to ensure innovations are accessible and beneficial to the widest audience.[31:13] Engaging more with the community will help embed inclusive design into the tech transfer process.[33:00] One of the biggest misconceptions is that inclusive design costs more.[37:01] Jutta shares advice for championing inclusion in our work. Look for the edges of the human starburst.Resources: Inclusive Design Research Centre OCAD UniversityJutta Treviranus - OCAD UniversityJutta Treviranus - LinkedInWe Count: IDRC's Inclusive Artificial Intelligence (AI) Initiatives

In honor of Disability Pride Month, I'd like to talk about a simple image that's quietly making a big difference around the globe. You might've seen it, a sunflower printed on a lanyard or pinned to someone's jacket, but maybe you weren't exactly sure what it meant. Well, that little sunflower is a lifeline, a subtle sign helping millions of people with invisible disabilities feel less alone, better understood, and genuinely welcome.Paul White, who’s joining me today, is the CEO and co-founder of Hidden Disabilities Sunflower. Back in 2016, Paul set out to change how we see disability, not just the ones that are obvious, but the ones you can't always see at first glance. Under his guidance, the Sunflower initiative has reached more than 40,000 locations in 53 countries, giving people space to simply exist without constantly needing to explain or justify themselves. In our chat today, Paul opens up about how the Sunflower started as a small airport project and grew into a worldwide movement, and he shares why places like universities and tech transfer offices have such an important role in creating environments where everyone truly feels they belong.In This Episode:[02:15] The Hidden Disability Sunflower was created in 2016. It was first used at the Gatwick Airport to help identify people with non-visible disabilities.[04:07] The sunflower was used because they wanted to create a symbol around positivity, happiness, strength, and confidence.[05:08] Disability is about barriers, and the sunflower is about what you can do.[06:23] A hidden disability is any disability that isn't visible. It can range from hearing loss to any type of chronic condition. Environments such as airports can also make people feel disabled. [09:46] Wearing the sunflower enabled a man with dementia to ride the bus and go to the sports club without his wife.[10:40] The sunflower program also offers training and advocates for rights within the community.[14:24] Sunflower has a membership platform, and the first thing you'll see is the training. There are also testimonials about how the sunflower has impacted people.[15:35] The hidden disability sunflower means that a wearer has a non-visible disability. You don't need to know or ask what that person's condition is, just give extra time, patience and understanding.[18:43] One in seven people have some form of disability. It should be up to an organization to allow a space for this person to access this area.[22:27] Universities are also using the sunflower. It helps spark the conversation and normalize disability.[23:42] The Scouts have also just introduced their first sunflower badge.[25:12] How the sunflower is being used as a symbol to help create independence in the Middle East. They have Global Partners all across the globe.[28:28] Paul's message would be for businesses and organizations to create an environment where people feel comfortable disclosing that they may have a non-visible disability.[29:45] Organizations could have newsletters, representation, or employ more disabled people.Resources: Hidden Disabilities Sunflower - Paul WhitePaul White - LinkedInHidden Disabilities Sunflower - InstagramHidden Disabilities Sunflower - FacebookHidden Disabilities Sunflower - X

Have you ever tried to picture the natural world without relying on sight? It’s a wild thought, but for Dr. Geerat J. Vermeij, it’s just how he experiences life. Blind since the age of three, Dr. Vermeij built an extraordinary career as an evolutionary biologist. He’s a MacArthur “Genius” Fellow, a celebrated author, and Professor Emeritus of Earth and Planetary Sciences at UC Davis.In our conversation, Dr. Vermeij walks us through the hidden stories that mollusk shells can tell us about evolution. Think underwater battles, survival strategies, and long-forgotten extinction events. He also introduces a powerful idea (no pun intended): that it’s not just energy that drives evolution, it's power. He digs into this more deeply in his book The Evolution of Power, which turns traditional theories on their head in the best possible way.But science is just part of the story. Dr. Vermeij also talks about what it’s been like to build a life in academia without sight including challenges, but also the deep gratitude he has for the mentors and collaborators who helped him thrive. He doesn’t sugarcoat it, but there’s something incredibly moving about the way he frames inclusion not as charity, but as essential to discovery.This episode kicks off our special series for Disability Pride Month, where we spotlight brilliant thinkers who expand how we see the world and what’s possible within it. Dr. Vermeij’s life reminds us that resilience, curiosity, and community can break barriers and reshape the story of science itself.In This Episode:[02:32] Dr. Vermeij talks about some of the things that he is the most proud of including his early insights including that shells are defenses against predators.[03:12] Shells get damaged but not necessarily lethally damaged. Most of his work has been a variation of this theme.[04:04] These adaptations are relatively recent in geological time. This means that the evolution between predator and prey has experienced spectacular adaptations.[05:16] He spent a lot of time studying in Guam, Panama, and Jamaica. Also New Guinea, Australia, and many more Islands. Every biologist should visit the tropics.[07:08] His main finding was to connect geological history with modern adaptation. He's also expanded to other organisms besides mollusks.[08:17] He's working on another book about what it's like to be a scientist. He and a colleague are also working on the evolution of semi-aquatic mammals.[09:39] Trying to understand evolutionary transitions and taking fossils into account is part of a larger project.[10:17] We should be diverse in the ways that we approach problems.[11:01] Unanswered questions in biology today including questions about natural selection.[12:40] What are the effects of climate change? A place to look are the changes in the effects of the geological records.[13:15] Dr. Vermeij talks about his book, The Evolution of Power. Energy doesn't do anything for you unless you use it.[16:39] How collecting shells as a boy shaped his love for the sciences. He's always had an interest in nature and the natural sciences.[20:13] We learn about his experience being a blind scientist. According to Dr. Vermeij, he has faced relatively few barriers. He had highly supportive potential mentors.[22:38] He's adapted well to his work, because he's had extremely amazing and helpful assistants.[24:03] All of his role models have been sighted, and have gone out of their way to help someone who was really interested in their work.[27:15] He's always had a successful career from the beginning.[28:32] Advice includes really liking what you're doing and working very hard. Have a strong curiosity about the world and the sense of what is important and what is not important.[29:39] For blind people, having readers can get you through materials so much faster than the computer. This is also how Dr. Vermeij met his wife.[31:56] He's had a long time view that we should pay less attention to people's identities and more to what they can actually do.[33:42] He's the most proud of his journey, and how he recognized something interesting and pursued knowledge. He's all about asking scientific questions.Resources: Dr. Geerat J. Vermeij - UC DavisThe Evolution of Power: A New Understanding of the History of LifeMacArthur Fellows

What if one of the most important medical breakthroughs of the 20th century began with a dead cow and a desperate young farmer? That’s exactly what happened in 1933, when 21-year-old Ed Carlson arrived in Madison, Wisconsin, carrying a bucket of blood and a mystery that would eventually lead to the discovery of warfarin. This unlikely starting point sparked years of relentless research by biochemist Karl Paul Link and his team, fueled by scientific curiosity, institutional support, and an unshakable belief in the power of perseverance.As we celebrate the 100th anniversary of the Wisconsin Alumni Research Foundation (WARF), we’re shining a light on the remarkable intersection of science, history, and Wisconsin legacy that made this discovery possible. Our guest is acclaimed journalist and author Doug Moe, whose storytelling career spans four decades and includes thousands of columns and multiple award-winning biographies. His latest work, Saving Hearts and Killing Rats: Karl Paul Link and the Discovery of Warfarin, brings this fascinating journey to life and was recently honored as the “Wisconsin Book of the Month” by the Milwaukee Journal Sentinel.In our conversation, Doug shares how he was first approached to tell this story, why it took him years to finally dive in, and what he uncovered in Link’s letters, archives, and personal history. We’ll hear about the personalities, the persistence, and the politics that surrounded the development of warfarin and explore why the impact of WARF and university-driven innovation still resonates so powerfully a hundred years later.In This Episode:[01:59] Tom Link, the son of Carl Paul Link, brought Doug a stack of articles and papers about his dad. This was a decade ago. [03:24] Doug knew Carl Paul Link was somebody who needed a biography written. This is the perfect time to highlight innovation and university research and tech transfer.[04:40] Link died in 1978, but the University of Wisconsin had an amazing archive of his work. Link was an avid letter writer. He would even put the time of his correspondence on his letters and it was often 2:30 in the morning.[06:09] The incoming correspondence was also a treasure trove.[07:24] Doug walks us through the story of the origin of warfarin, beginning with a dead cow and a bucket of blood. [09:02] There was a connection between sweet clover hay and cow's dying because their blood couldn't clot.[10:15] Scientists spent six years trying to figure out why this was. They eventually discovered a hemorrhagic agent that they were able to reproduce synthetically.[11:27] They faced many hurdles including how long it took to have success. Perseverance is at the top of the success list. [13:10] People doubted Link's story, but Ed Carlson was real. [15:14] Warfarin is an anticoagulant, but it can also be used as a rat poison.[17:10] How warfarin got its name. [19:06] The tipping point for warfarin becoming commonly accepted was when President Eisenhower had a heart attack in 1955.[20:34] Link had a big personality. He was likely manic depressive or bipolar. He was a complex individual. He was also a fancy dresser. [22:52] Link was also into activism on campus. [25:00] He also had controversies. [28:44] We learn about Link's blowout with Harry Steenbock.[29:25] WARF's involvement in warfarin becoming available to the public. WARF helped with the patent and donated money to the University of Wisconsin.[31:37] WARF's 100th anniversary, and the power of university tech transfer and public research foundations.[32:29] Doug is glad that his book highlights the importance of innovation and tech transfer. [34:29] What Doug would like readers to take from the book.Resources: Saving Hearts and Killing Rats: Karl Paul Link and the Discovery of WarfarinDoug MoeDoug Moe - LinkedInWisconsin Alumni Research Foundation:WARFKarl Paul Link

What happens when climate innovation isn’t just a buzzword but a blueprint for real change? In this episode, we explore how climate-focused technologies are being developed, commercialized, and scaled in ways that go far beyond traditional models. My guest, Josh Dorfman, brings a rare mix of experience in both business and policy, with a track record of building ventures that reduce emissions while delivering everyday value. Josh is the co-founder and CEO of Plantd, a company creating carbon-negative building materials that was recently named one of the world’s most innovative by Fast Company. He also launched The Lazy Environmentalist, a media brand that made sustainability more accessible, and now runs Supercool, a platform spotlighting climate tech with real-world impact. With past work ranging from startups to established brands like Brita, Josh offers a grounded, actionable look at how innovation, sustainability, and commercialization intersect and what that means for tech transfer offices and startups who want to make a difference.In This Episode:[02:17] Thinking about climate goes back to being an English teacher in China in the 1990s. He saw the future of a billion cars in China and never shook the thought. [04:36] He was involved in tech in the States, but wanted to do something about climate. He started a sustainable furniture company in 2004. This eventually led to where he is now.[05:12] Plantd is working on carbon negative construction materials made out of grass and resin.[06:23] They talked to green builders, but the scale wasn't there. They decided to reach out to the largest builders in the market.[07:32] They opened a path to go to market with D.R. Horton, one of the biggest builders in the country.[10:01] First steps for building sustainability into your tech transfer strategy include being integrated in the tech ecosystem that many cities are building around the country.[11:07] Building connectivity and getting integrated in the ecosystem is paramount.[12:05] Sustainability is built into the product. Go fast but don't over commit to the wrong path.[13:42] Supercool focuses on technologies that reduce emissions and improve everyday life. [14:09] Technologies include WasteLess, a food waste prevention company. Another one includes Upway which is an infrastructure for getting pre-owned bikes. It creates a built-in market for e bikes.[18:06] When large brands commit, they're really committed.[19:40] Working with Brita helped eliminate some disposable water bottles.[20:46] How policy shapes the space between innovation and government. [23:05] The global march towards the low carbon future is inevitable.[24:20] This is a huge time for cultivating environmentally friendly technology and entrepreneurship.[26:16] Advice includes lean into sustainability strategically just like bringing any other product to market.[27:50] Focus on the outcomes and the results for the business that your product will enable. Use sustainability as a differentiator.[28:26] Josh is excited about the concept of urban mining.[29:11] In the west, we have all the stuff that contains all these materials.[31:31] Focus on solutions. [32:44] Josh shares his hope for the future. Sustainability is an opportunity for all ages.Resources: PlantdJosh Dorman - LinkedInSupercoolLazy EnvironmentalistWasteLess SolutionsUpway

What if universities had a smarter way to surface the innovation already happening across their campuses? In this episode, I’m joined by Steven Lehmann, Managing Director of Stargaze at Portal Innovations, and Ashish Uppala, Head of Engineering and Product for Stargaze. Steven brings over a decade of experience in venture building and university innovation ecosystems, including leading the University of Chicago’s $20 million pre-seed fund and authoring the Innovation Ecology Substack. Ashish, a former CTO of scite.ai and an expert in AI and machine learning, combines deep technical knowledge with a passion for mapping biotech innovation. Together, they share how Stargaze is helping universities navigate today’s funding challenges by identifying hidden opportunities in their research ecosystems. From integrating complex data sources to predicting commercialization potential, Stargaze is transforming how institutions connect innovation with impact.In This Episode:[01:50] Portal has been around for about 5 years. The goal has been to build infrastructure that's necessary to commercialize innovation in areas that are over-scienced but underfunded or don't have the resources to take the innovations to market.[02:51] They've been building the infrastructure to get academic ideas for a Series A investment.[03:06] They needed to find the scientist and the ideas to plug into their infrastructure. Stargaze is like Google Maps for innovation.[04:12] Stargaze builds rich maps of scientific ecosystems. They use AI, network science, and reason models.[06:33] Stargaze helps keep track of all the possibilities and move from reactive to proactive.[08:24] They are equipping innovators and scouts with understanding the commercial potential of research.[09:07] They can build a picture to understand the potential landscape.[11:41] We talk about who's working on the project.[13:18] The core of Stargaze is organizing information around innovation so that they can feed it into different matching and scoring algorithms. [15:17] Because of the information they have, they find investors that are interested in whatever the researcher may be working on.[16:55] How Innovation biomarkers can be helpful in an emerging system.[18:47] Finding the signals of who can work together in a meaningful way toward a particular problem.[21:12] We talk about privacy and security. Data and license is scoped to that person or project. [25:26] The recent rate of innovation has been crazy. [27:54] Thinking about synergies and risk to the core business.[29:18] How Tech Transfer professionals can implement Stargaze by signing up to the Stargaze network.[31:48] It's very user friendly.Resources: Steve Lehmann - Portal InnovationsSteven Lehmann - LinkedInAshish UppalaAshish Uppala - Portal InnovationsAshish Uppala - LinkedInStargaze NetworkOpenAlex

The world of software innovation is evolving faster than ever, and Tech Transfer professionals are being asked to make critical decisions around open source, copyright, patents, and AI. In this episode, we take a deep dive into this complex landscape with Dan Dardani, Director of Physical Sciences and Digital Innovations Licensing and Corporate Alliances at Duke University. Dan brings over two decades of experience to the conversation, including nearly 20 years at MIT and his long standing leadership in AUTM’s Software Course Committee.Dan shares his practical insights into how Tech Transfer offices can navigate the tricky decision between copyright and patenting software, how to handle open-source licensing in research environments, and what to consider when commercializing digital tools. He also offers guidance on machine learning and artificial intelligence, addressing real-world questions around IP ownership, data licensing, and the legal gray areas created by emerging technologies.Whether you’re just starting to build policies for software disclosures and AI-related inventions, or you’re looking to refine your office’s strategy, Dan’s perspective is both grounded and forward-thinking. His advice, drawn from decades of hands-on experience, will help you understand not just what’s changing in the digital IP world, but how to keep up and lead through it.In This Episode:[01:57] Patents and copyrights aren't mutually exclusive. They protect different aspects of the software. Software comes with copyright right out of the box.[02:44] Patents are more difficult and more expensive to obtain. Courts have recently made it more difficult, but it still can be done.[03:23] When deciding between copyright or patent, ask what the innovation is. Is it a transformative leap? [04:57] You need to tell a compelling story and emphasize the transformative ability of your software.[05:53] The last thing to consider is if there's a commercialization strategy.[06:48] Examples of software innovations that have met the criteria for patentability. Diamond v. Diehr in the 1980s. Transformative is a key concept in IP thinking.[08:03] We have to be more careful with applying for algorithms now. [09:11] Workhorse apps and code may be more suited for copyright protection than patents.[10:22] Copyright is the first line measure for protecting innovation.[10:46] Open-source is vital to software innovation. Risks dealing with open source innovations include third-party code issues, sponsorship issues and open source compliance issues.[11:45] It's important to not commit copyright infringement by releasing someone else's code.[13:34] Balancing a researcher's desire to use open source licenses and the universities need to protect IP and pursue commercialization. Education and early communication.[15:49] There are multiple ways to license, including dual licensing strategies.[16:14] An example of FFTW using a hybrid licensing model.[18:13] Releasing code as part of the peer review process.[21:55] Focusing on machine learning and AI.[22:07] Addressing IP ownership when working with these technologies. Understanding the difference between being a data producer and a data user.[23:42] It's crucial to understand the layers and document the data sources.[24:24] Navigating inventorship when AI is involved. A human needs to be named the inventor.[26:01] There's going to be an evolution of the laws regarding patents and AI. The laws are going to need to adapt to address inventorship and ownership.[28:26] Advice for TTOs to mitigate risk that might infringe on existing IP. It gets complicated, and the best advice is to start with a clean house.[31:13] Distinguishing between the types of data used for licensing.[33:49] Advice for tech transfer offices that are just beginning to think about these issues and develop policies around proper software hygiene and AI related inventions.Resources: Daniel Dardani - Duke UniversityDaniel Dardani - LinkedInInnovation Without Borders: Insights from the ISTA Forum 2024Diamond v. DiehrFFTW

AI is no longer just a concept in IP. It’s part of how teams work, make decisions and create value. In this episode I talk to Dr. Marcia Chang, VP of IP Operations and Client Success at Tradespace. Dr. Chang has over 20 years of experience in IP strategy, operations and commercialization and has a unique blend of engineering and legal expertise. She has a Ph.D. in Electrical Engineering from Cornell University and a J.D. from Santa Clara University she’s held leadership roles at companies like Applied Materials, Metawave Corporation and Hewlett Packard Enterprise. She was also recognized as one of the Top 50 Women Leaders in Tech Law. At Tradespace she’s now at the forefront of using AI driven approaches to transform how IP is managed and commercialized. Dr. Chang explains how Tradespace is helping universities and companies streamline the entire IP lifecycle. By using AI to simplify invention disclosures, evaluate technical content and identify commercial opportunities the platform gives IP teams clearer insights and greater strategic impact. For Tech Transfer offices with limited resources and growing demands Tradespace is a practical way to prioritise what matters and move more technologies to real-world application. We discuss adapting to new technology with a curiosity and willingness to learn. Along with practical tips for building smarter, more connected systems. Dr. Chang also reflects on how AI went from being a tool she was sceptical of to one she now advocates for. In This Episode:[01:41] Dr. Chang gives us an overview of Tradespace. Its mission is to empower IP teams to focus on strategy and unlock the value of their portfolios.[02:29] The name Tradespace comes from mapping choices onto a multi-dimensional trade space. Teams can weigh alternatives, trade-offs, and find the optimal path.[03:15] It's their goal to help teams manage IP better and even make IP better.[04:02] Tactically Tradespace can help IP teams translate technical concepts in the business concepts. Strategically they focus on communicating more value.[05:54] They help teams sift through the technical information in a short amount of time.[06:08] Key tools that Tradespace offers. They have tools that help with invention disclosure and use AI to make the submission process easier.[08:34] They have the ability to streamline the entire IP process in a single end-to-end platform.[09:27] The data is also very secure.[10:31] How they help bring innovations to market. They provide AI-assisted commercialization with automatic matching of potential partners along with generating text summaries.[11:57] They've helped customers identify dormant IP assets and uncovered use cases that hadn't been thought of before.[14:22] We talk about the specific ways that AI is reshaping the field of IP management. This includes better portfolio management and faster decision making.[18:22] Getting comfortable with AI begins with education.[20:55] Challenges in tech transfer today include budget restraints and having to do more with less. AI tools can help with the entire process making things faster, cheaper, and better.[23:03] They've seen backlogs cleared. It's like adding a member to your team.[23:57] Potential trends include more transformative technologies unlocking innovation.[26:03] Dr. Chang talks about her inspiration and how she always took the road less traveled.[29:56] Valuable lessons include always being humble.[32:54] Tradespace has unlocked over $100 million of potential revenue for clients. They hope to scale as AI evolves.[34:56] AI is evolving to become a partner in our work.Resources: TradespaceDr. Marcia Chang - LinkedInTomorrow's Lawyers: An Introduction to your Future

When you start a biotech company, equity isn't just a line on a spreadsheet. It can literally determine who gets to keep pursuing their dream and who has to step aside. In this episode, we're digging into equity distribution, an aspect of launching a startup that's easy to overlook but critically important. It shapes whose ideas ultimately make it from the lab bench to the real world.My guest today is Dr. Jahanara Ali, founder of Longitude Ventures Consulting. Dr. Ali has spent years working with universities, biotech startups, and investors, helping them transform research into successful businesses. Her recent three-part series, "Dividing the Equity Pie," explores how equity was distributed among founders and investors in biotech companies that went public from 2021 to 2023, and her insights reveal some fascinating trends.We'll unpack those insights, explore the differences between companies launched by investors versus those started by founders, and talk honestly about the persistent gender gaps in equity stakes. Whether you're a researcher wondering how equity works, a tech transfer specialist representing inventors, or an entrepreneur setting up your own startup, you'll leave this conversation with practical tips and a clearer understanding of how to manage equity fairly and effectively.In This Episode:[02:08] We learn about how Dr Ali ended up in biotech and venture consulting. She was a scientist but she knew she wanted to move into the business side.[03:14] She began working in Tech Transfer and joined an early stage biotech startup to learn about the business side.[04:02] Through her various experiences she became an expert in equity, licensing, and early stage development.[05:30] She dove deeper and deeper into how to divide equity for biotech companies.[06:02] She discovered that equity was all over the place for academic founders.[07:34] Academic founders usually do better with their equity shares if they negotiate for themselves.[08:52] She discovered that founders who developed foundational IP or an inventor who took an operational role usually end up with more equity than inventors who stay in academia.[09:27] It's important to educate faculty members and licensing offices on this data.[11:12] Advice for academic inventors includes to partner with tech licensing offices but negotiate the equity component separately.[12:05] Key differences between investor-launched and entrepreneur-launched biotech companies.[13:43] Founding investors retained about 30% of equity at IPL. Founding entrepreneurs retained about 14% of equity.[15:13] Companies launched by VCs raised over $100 million. This was a lot more than the entrepreneur launched companies.[16:08] Lessons include understanding how difficult it is to succeed. Have experienced people around you who have done it before.[17:18] Out of 243 founders, only about 51% were on the cap table at IPO. The other 50% just drops off for whatever reason.[18:47] If you're going to raise money, dilution will happen.[19:50] Gender disparities among founders. [20:15] About 85% of the founders were male. Women were 10%. Investors started 5% of the companies.[21:51] Young women should include male mentors in their professional network. [23:19] There are Angel networks that do invest in women entrepreneurs.[24:18] There is an opportunity to standardize academic equity.[25:03] Key insights for academic inventors.Resources: Dr. Jahanara Ali - LinkedInLongitude Ventures Consulting - LinkedIn

When cutting‑edge science collides with the realities of commercialization, tech transfer stops being paperwork and starts shaping the future of innovation. That intersection is exactly where European patent attorney and IPKat writer Rose Hughes has built her career, and today she’s here to break down what the latest headline decisions mean for anyone navigating patents on this side of the Atlantic. Dr. Hughes traces her journey from a PhD in infection‑immunity at University College London to training with Marks & Clerk, six years in‑house at AstraZeneca’s Cambridge R&D hub, and now a role at boutique firm Evolve, all while sharpening her public voice through IPKat’s mentored blogging model. In our conversation, Dr. Hughes unpacks the Enlarged Board’s looming opinion on reading claims in light of the description and why a Philip Morris case shows the hidden danger of boiler‑plate definitions. She explains G 2/21’s guidance on post‑field data using a polymorph dispute where vague promises of stability fell short, and she highlights how the UPC’s early Abbott v Sibio ruling suggests Europe’s new patent court is echoing EPO practice on functional language and added‑matter tests. We also dig into an Amgen peptide‑manufacturing opposition that weighs patent protection against trade secrets, and a recent Board decision where an AI‑driven cell‑analysis method collapsed for lack of technical character and data support.Dr. Hughes offers practical takeaways for university Tech‑Transfer offices from timing filings to fast‑moving science and preparing for AI tools that may automate drudge work but not strategic thinking. Along with candid advice for newcomers on following the science you love and using AI to focus on high‑value patent strategy.In This Episode:[05:16]  Dr. Hughes explains how launching the IPKat blog let her break down complex patent cases, deepen her own understanding, and build a go‑to resource for the European IP community.[08:22] We learn about some interesting cases that Dr Hughes has worked on recently. [09:33] The best IP is going to be grounded in the most exciting and innovative science.[10:06] We discuss some Enlarged Board of Appeals decisions and opinions about descriptions including the Philip Morris tobacco case.[13:05] Her advice is to be aware of boilerplate definitions. Also watch out for AI definitions.[15:15]  A deep dive into the Polymorph Patents ruling. [16:18] The Board of Appeal applying G2/21 said that you can use post-published data, but you can't just base it on sweeping statements in your application. Connect your features with how they are solving a problem.[17:43 ] Insights on the UPC’s Abbott  decision.The new court is likely to follow EPO precedent on added‑matter and claim interpretation.[20:27]  Dr. Hughes talks about an Amgen peptide manufacturing‑method case. [23:47]  A recent Board ruling on AI‑enabled cell‑therapy which uses AI to analyze the cell. (T 0660/22, Cell analysis/NIKON)[26:27]  There will be an increased use of AI tools and there will be challenges with how this is handled. [00:29:08] How tech transfer offices should approach European patent practice. There are significant differences between the two.[30:19]  The gap in antibody claim scope between the US and Europe is widening. [32:07] Predictions for trends and changes that could impact European patent practice and tech transfer in the next few years.[34:16] Advice for new patent attorneys and agents that are entering the field. Focus on the science that you are interested in. Gain as many different experiences as you can.[35:47] AI isn't going to take our jobs away; there will still be a role for patent attorneys. It will  automate the tedious processes.Resources: Dr. Rose Hughes - BloggerRose Hughes - LinkedInEvolve Pharmaceutical IPThe IPKat

This episode will illustrate how scientific research and tech commercialization can create a powerful impact. I'm excited to have Dr. Valwynne Faulkner on the show today. She is a postdoctoral researcher at the Francis Crick Institute and a LifeArc Knowledge Transfer Innovations Fellow. Her fascinating work spans cutting-edge molecular biology research and technology transfer.Val walked me through the work her team is doing with CRISPR to expose new ways of tackling tuberculosis, even the stubborn drug‑resistant strains. She also opened up about how the LifeArc fellowship is pulling her deeper into tech transfer, what she is learning about patents and partnerships, and why she thinks regulators need a seat at the table from day one.Whether you spend your days at the bench or in an office turning ideas into products, Val’s story shows how a curious mind and a collaborative spirit can move discoveries out of the lab and into the world.In This Episode:[01:12] We learn about Dr. Faulkner's current research at the Francis Crick Institute studying mycobacterium tuberculosis. [01:50] At the systems chemical biology lab they are developing CRISPR-based molecular tools that we can use to precisely control and silence genes.[02:13] This helps them understand the functional roles of genes in TB and response to antimicrobial drugs.[03:05] The hope is that the research will uncover new drug targets and help combat antimicrobial drug resistance.[03:46] Dr. Faulkner talks about the LifeArc Knowledge Transfer Innovations Fellowship. It helps teach scientists how to transition into careers within tech transfer. They get formal training and all aspects.[05:14] She learned about the program by chance. LifeArc was at the Francis Crick for a career event. [06:15] Her diverse experience across academia, industry and regulatory labs has given her a holistic perspective on research translation.[07:38] AUTM is a partner with the fellowship and gives them access to all of the online tools and learning centers. Along with excellent mentors and experienced professionals.[08:40] Insights gained from the AUTM 50th event. It's amazing how many stakeholders are involved.[09:37] Bridging the gap between scientific research and commercialization. The AUTM  Annual meeting has been crucial in facilitating knowledge exchange and networking.[10:49] A key challenge is navigating the complicated IP landscape. [11:57] Dr. Faulkner is excited about advancements in antimicrobial drug discovery.[13:04] Advice includes reaching out and asking questions and seeking things like fellowships. Be open to interdisciplinary collaborations.[13:53] The future of research innovation will be shaped by strong academic and commercial partnerships.Resources: Dr. Valwynne Faulkner - Francis Crick InstituteLifeArc

Building inclusive workplaces is not just good ethics, it is a major catalyst for innovation, creativity, and long term success. In this episode we take a closer look at how tech transfer offices can harness the untapped potential of neurodivergent talent and why doing so could transform not just individual careers but entire organizations.My guest is Andy Williamson, founder of Welcome Brain Consulting a UK-based consultancy pioneering neurodiversity inclusion in workplaces worldwide. Andy has spent over a decade helping organizations rethink how they hire, train, and support neurodivergent individuals from private companies to public institutions. His work includes developing the UK Industry Standard Neurodiversity in Events Checklist and advising on strategies that make workplaces more welcoming and effective for all kinds of thinkers. Andy shares how TTOs can create hiring practices that break down barriers, design workspaces that support focus and creativity, and foster cultures where every mind is valued. He explains why adapting communication styles, offering small workplace adjustments, and tracking the right metrics can make a huge difference, and why the business case for neuro inclusion is just as strong as the moral one. This is a thoughtful and practical conversation for anyone serious about building innovation ecosystems leaving no talent behind. In This Episode:[02:07] Andy shares why he founded Welcome Brain and some services they provide.[02:42] Andy talks about getting incredible results when tailoring learning for neurodivergent young people.[03:52] They help organizations support neurodiverse individuals within that organization.[04:25] They are currently working with the government with recruitment and hiring.[05:10] As many children are getting diagnosed, so are their parents. There are many neurodivergent adults.[07:37] Neurodiversity means thinking differently. This is what has made America great.[08:53] TTOs are hubs for translating research into real world impact. There are certain skills inherent in neurodivergent people that can be really helpful with systems thinking and seeing things that others miss.[10:23] Innovation is thinking differently. That's what neurodivergent people do. Incredible ideas and tremendous creativity.[11:25] Neurodiverse teams can be more productive. Andy talks about roles that neurodivergent people would excel at.[13:30] We talk about hiring and the recruitment process for neurodivergent people. The job description language, the screening process, and the interview process can filter out neurodivergent people.[15:59] Interview skills aren't the same as the skills required for the job.[16:24] Send interview questions in advance so people can prepare.[18:10] Being neuro inclusive will make you more money. Retention rates are also higher.[21:14] Office space and redesigning workspaces to increase focus. Things that can be done include creating acoustics around each zone.[23:41] Fostering psychological safety for neurodivergent individuals to share their needs and avoid stigma. Seeing other neurodivergent people creates a sense of safety.[27:28] Modeling inclusive behavior to shift team culture.[28:17] Managers need to be involved and communication is key[30:03] We learn about Welcome Brain's Certification Program. The initiatives need to be evaluated and measured.[33:12] We discuss the Neurodiversity In Events Checklist.[38:25] What TTOs should do to start creating neurodivergent inclusive environments. Resources:Welcome Brain Neurodiversity ConsultingAndy Williamson - Welcome Brain Neurodiversity ConsultingWelcome Brain - LinkedInAndy Williamson - LinkedInNeurodiversity In Events Checklist

Innovation isn’t just evolving—it’s accelerating, fragmenting, and reshaping everything in its path. In this episode, we dive into what that means for the world of technology transfer, where traditional systems are being pushed to adapt or risk falling behind. If you’ve ever wondered how Tech Transfer Offices can keep up with the chaos of rapid innovation, this conversation will give you both clarity and direction.Our guest is Nick Webb, a bestselling author, futurist, and innovation strategist who has worked with some of the world’s top brands and holds more than 40 patents. He’s written influential books like The Innovation Mandate and What Customers Crave and leads consulting work that helps organizations future-proof their approach to innovation. In this episode, he brings that expertise to the challenges and opportunities facing universities and research institutions today.Nick talks about how TTOs can streamline operations, embrace smart automation, and build internal communication strategies that actually work. He shares how commercialization can be both profitable and socially impactful, how to better engage inventors in the process, and why building strong industry partnerships is no longer optional. It’s a fast-paced, eye-opening discussion for anyone working at the intersection of research and real-world impact.In This Episode:[01:44] His book, Chaotic Change was a look back at his 44 years in the innovation space. Things we're slow and small. When the internet came out everything was connected and digitized. Things became fast and big.[02:37] TTOs need to develop best practices and technologies to handle the amount and volume of a super complicated landscape.[03:02] With the AI shift and the next wave of chaos we'll see rapid adoption of new best practices, technologies, and systems.[03:41] One of the biggest inefficiencies is bureaucracy.[04:24] The importance of communicating to leaders and selling value as TTOs. The technology to accelerate is also important.[05:09] Commercialization is the ultimate force of impact. [06:06] Nick runs an AI lab and talks about the impact of AI Tech Transfer. We also need to keep our real intelligence in the process.[08:30] Nick talks about protecting IP for commercial success. Great strategic partners are a big help.[09:53] This would be a good time to reevaluate policies to see if it's a document that will increase technology licensing.[10:49] The importance of internal communication strategies for TTO offices.[11:34] Innovation Superstar Bootcamp has a master's and a startup program. It's about making the complexity of innovation management fun and understandable.[14:02] Striking the right balance between licensing startups and open Innovation models.[15:43] Collaborations and making the best partnerships work.[18:02] Practical steps to optimize operations without sacrificing impact. It starts with having a strategic plan.[19:26] Getting researchers interested in the commercialization process and thinking beyond their labs.[20:52] Lessons from Innovation Mandate that can be applied to TTOs to modernize their operations.[21:43] Taking a triage approach towards everything.[22:35] Don't waste time on technologies that don't stand a chance. Fast track methodologies. Sell your value proposition to get permission to move.[24:05] Monetizing non-traditional IP assets.[25:48] Trends to pay attention to. The experience ecosystem, the creation of AI artifacts, and business model innovations.[27:52] The Importance of being able to sell your value.[30:10] ESN an Enterprise Social Network.[31:05] Predictions for the future include automation, being hyper technical, and hyper human.Resources: Nick WebbWebb LogicNicholas Webb - LinkedInNicholas J. Webb - FacebookThe Innovation MandateWhat Customers CraveOther BooksLeaderLogic, LLCInnovation Superstar BootcampThe Healthcare Cure

Could worms be the missing piece to treating allergies and autoimmune diseases? That’s the exciting idea that’s driving today’s guest, Dr. Andrea Choe, a scientist, doctor and biotech founder on a mission to change the way we think about human health.Dr. Andrea Choe is the CEO and co-founder of Holoclara, a biotech company that’s changing how we treat allergies and autoimmune disorders. While working on her PhD at Caltech, Andrea discovered a unique pheromone language shared by roundworms which led to insights in evolutionary biology and immunology. Today her research is the foundation of Holoclara’s mission to help millions suffering from allergies and autoimmune disorders.Today we’ll talk about how regions of the world where people live alongside worms have much lower rates of these conditions — and how Holoclara is working to tap into that evolutionary relationship in the form of safe, orally administered treatments. We’ll discuss the challenges of translating lab science into real world medicine, the regulatory hurdles of building a new class of drugs and why Andrea believes innovation should feel unconventional. And throughout it all she’s driven by one clear North Star: helping patients and families get relief.In This Episode:[01:52] Andrea shares how she made the roundworm discovery. Her thesis was on understanding the evolution of molecularcommunication between worms. She ended up discovering the shared unique pheromone language.[03:20] There were no allergies or autoimmune diseases before the 1900s.[04:29] Holoclara reflects the idea of completeness. This is Andrea's driving philosophy in life.[05:17] She believes that having a multidisciplinary approach to anything is always the best.[06:23] We learn about some of the many challenges that Andrea and her company has gone through.[09:43] They're trying to bring forward an entirely new class of medicine.[13:06] We learn about Andrea's experience with tech transfer and collaboration between Caltech and industry.[14:35] Approaching the regulatory path and listening to FDA guidance.[17:14] We learn about the team at Holoclara from R&D to clinical development.[18:25] The unconventional use of worms and innovation.[20:33] The treatment possibilities are far reaching. [21:06] Andrea shares how she's always motivated. She's really interested in figuring out how to change lives and get rid of chronic debilitating diseases. Resources: HoloclaraAndrea Choe - HoloclaraAndrea Choe - LinkedIn